Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
第一作者:
George,Pentheroudakis
第一单位:
Department of Medical Oncology, Ioannina University Hospital, Ioannina, Greece. gpenther@otenet.gr
作者:
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药(Antineoplastic Agents);结直肠肿瘤(Colorectal Neoplasms);DNA突变分析(DNA Mutational Analysis);表皮生长因子(Epidermal Growth Factor);女(雌)性(Female);基因, ras(Genes, ras);疾病遗传易感性(Genetic Predisposition to Disease);基因型(Genotype);糖蛋白类(Glycoproteins);人类(Humans);胞间信号肽类和蛋白质类(Intercellular Signaling Peptides and Proteins);男(雄)性(Male);中年人(Middle Aged);磷酸肌醇3-激酶(Phosphatidylinositol 3-Kinase);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);RNA, 信使(RNA, Messenger);回顾性研究(Retrospective Studies)
DOI
10.1186/1471-2407-13-49
PMID
23374602
发布时间
2021-10-21
- 浏览0
BMC cancer
49页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文